Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
Artificial intelligence
|
436,719
|
14,087
|
B
|
Low
|
2
|
Asperger syndrome
|
339,849
|
10,962
|
B
|
High
|
3
|
Schizophrenia
|
203,605
|
6,567
|
FA
|
High
|
4
|
Autism spectrum
|
202,155
|
6,521
|
B
|
High
|
5
|
Attention deficit hyperactivity disorder
|
174,399
|
5,625
|
GA
|
Mid
|
6
|
MDMA
|
162,201
|
5,232
|
B
|
Mid
|
7
|
Methamphetamine
|
161,518
|
5,210
|
GA
|
Mid
|
8
|
Amyotrophic lateral sclerosis
|
161,245
|
5,201
|
B
|
Top
|
9
|
Education
|
141,680
|
4,570
|
C
|
Unknown
|
10
|
University of Oxford
|
134,913
|
4,352
|
GA
|
Low
|
11
|
Stanford University
|
130,311
|
4,203
|
B
|
Low
|
12
|
Multiple sclerosis
|
127,332
|
4,107
|
C
|
High
|
13
|
Cannabis (drug)
|
124,614
|
4,019
|
B
|
High
|
14
|
Autism
|
114,734
|
3,701
|
C
|
High
|
15
|
Synesthesia
|
114,007
|
3,677
|
C
|
Mid
|
16
|
Psychology
|
113,033
|
3,646
|
C
|
Low
|
17
|
Rabies
|
112,097
|
3,616
|
B
|
Mid
|
18
|
Lysergic acid diethylamide
|
110,975
|
3,579
|
B
|
High
|
19
|
Massachusetts Institute of Technology
|
105,984
|
3,418
|
GA
|
Low
|
20
|
Shingles
|
105,157
|
3,392
|
GA
|
Mid
|
21
|
Lobotomy
|
103,440
|
3,336
|
B
|
Mid
|
22
|
University of Pennsylvania
|
102,474
|
3,305
|
B
|
Low
|
23
|
Sertraline
|
100,427
|
3,239
|
B
|
High
|
24
|
Everywhere at the End of Time
|
99,914
|
3,223
|
FA
|
Low
|
25
|
Bupropion
|
98,128
|
3,165
|
FA
|
Mid
|
26
|
Alzheimer's disease
|
98,067
|
3,163
|
C
|
High
|
27
|
Post-traumatic stress disorder
|
93,185
|
3,005
|
B
|
High
|
28
|
Major depressive disorder
|
92,946
|
2,998
|
FA
|
High
|
29
|
New York University
|
92,097
|
2,970
|
B
|
Low
|
30
|
Psilocybin mushroom
|
89,339
|
2,881
|
B
|
Mid
|
31
|
Methylphenidate
|
87,796
|
2,832
|
B
|
Mid
|
32
|
Mental disorder
|
86,914
|
2,803
|
C
|
Top
|
33
|
University of California, Berkeley
|
86,585
|
2,793
|
B
|
Low
|
34
|
Amphetamine
|
84,391
|
2,722
|
FA
|
Mid
|
35
|
Dopamine
|
82,407
|
2,658
|
GA
|
High
|
36
|
Fluoxetine
|
79,346
|
2,559
|
B
|
High
|
37
|
Psychosis
|
79,011
|
2,548
|
C
|
High
|
38
|
Consciousness
|
77,091
|
2,486
|
GA
|
Top
|
39
|
Melatonin
|
76,232
|
2,459
|
B
|
Mid
|
40
|
Body dysmorphic disorder
|
75,838
|
2,446
|
C
|
Mid
|
41
|
Caffeine
|
74,520
|
2,403
|
B
|
High
|
42
|
Education in the United States
|
74,086
|
2,389
|
B
|
Low
|
43
|
Serotonin
|
73,255
|
2,363
|
B
|
High
|
44
|
Psilocybin
|
73,100
|
2,358
|
FA
|
Mid
|
45
|
Tourette syndrome
|
72,295
|
2,332
|
FA
|
Mid
|
46
|
Sleep paralysis
|
70,942
|
2,288
|
B
|
Low
|
47
|
Myasthenia gravis
|
70,654
|
2,279
|
B
|
Mid
|
48
|
Emotion
|
66,599
|
2,148
|
B
|
Mid
|
49
|
Dementia
|
66,018
|
2,129
|
B
|
Top
|
50
|
Opium
|
65,511
|
2,113
|
B
|
Mid
|
51
|
Monique Ryan
|
64,409
|
2,077
|
Start
|
Low
|
52
|
Artificial neural network
|
64,301
|
2,074
|
C
|
Unknown
|
53
|
Magnetic resonance imaging
|
63,416
|
2,045
|
GA
|
High
|
54
|
Pareidolia
|
59,849
|
1,930
|
B
|
Low
|
55
|
Sociology
|
59,803
|
1,929
|
GA
|
Low
|
56
|
Neuralink
|
58,867
|
1,898
|
Start
|
Low
|
57
|
Modafinil
|
58,831
|
1,897
|
B
|
Mid
|
58
|
Prion
|
58,634
|
1,891
|
GA
|
High
|
59
|
Dementia with Lewy bodies
|
57,876
|
1,866
|
FA
|
High
|
60
|
Phencyclidine
|
57,604
|
1,858
|
C
|
Mid
|
61
|
Phineas Gage
|
57,384
|
1,851
|
B
|
Low
|
62
|
Deep learning
|
57,109
|
1,842
|
C
|
Mid
|
63
|
Color blindness
|
55,293
|
1,783
|
C
|
Mid
|
64
|
Opioid
|
54,465
|
1,756
|
B
|
High
|
65
|
Pineal gland
|
54,321
|
1,752
|
B
|
Mid
|
66
|
Virtual reality
|
54,233
|
1,749
|
B
|
Low
|
67
|
Savant syndrome
|
54,142
|
1,746
|
C
|
High
|
68
|
Déjà vu
|
53,646
|
1,730
|
Start
|
Low
|
69
|
Oxytocin
|
51,671
|
1,666
|
B
|
Mid
|
70
|
Creutzfeldt–Jakob disease
|
50,472
|
1,628
|
B
|
Mid
|
71
|
Andrew D. Huberman
|
50,303
|
1,622
|
Start
|
Unknown
|
72
|
Nicotine
|
49,412
|
1,593
|
B
|
High
|
73
|
Epilepsy
|
49,253
|
1,588
|
GA
|
High
|
74
|
University College London
|
47,322
|
1,526
|
B
|
Low
|
75
|
Nervous system
|
47,143
|
1,520
|
B
|
Top
|
76
|
Vagus nerve
|
46,531
|
1,501
|
C
|
High
|
77
|
Robot
|
46,512
|
1,500
|
B
|
Low
|
78
|
Mind
|
46,331
|
1,494
|
C
|
Mid
|
79
|
Gamma-Hydroxybutyric acid
|
45,712
|
1,474
|
B
|
Mid
|
80
|
Insomnia
|
44,149
|
1,424
|
B
|
High
|
81
|
List of people who awoke from a coma
|
43,238
|
1,394
|
List
|
Low
|
82
|
Self-driving car
|
41,463
|
1,337
|
B
|
High
|
83
|
Dextroamphetamine
|
41,128
|
1,326
|
B
|
Low
|
84
|
Dream
|
40,711
|
1,313
|
B
|
Mid
|
85
|
Brain
|
40,024
|
1,291
|
GA
|
Top
|
86
|
Amygdala
|
39,494
|
1,274
|
C
|
Top
|
87
|
Spinal cord
|
38,800
|
1,251
|
C
|
Top
|
88
|
Restless legs syndrome
|
38,754
|
1,250
|
B
|
Low
|
89
|
Norepinephrine
|
38,720
|
1,249
|
GA
|
High
|
90
|
Artificial general intelligence
|
38,431
|
1,239
|
C
|
Unknown
|
91
|
Jeremy Bentham
|
38,351
|
1,237
|
B
|
Low
|
92
|
Memory
|
37,758
|
1,218
|
C
|
High
|
93
|
Developmental coordination disorder
|
37,701
|
1,216
|
B
|
Mid
|
94
|
Psychedelic drug
|
37,570
|
1,211
|
B
|
Mid
|
95
|
Drug
|
37,468
|
1,208
|
C
|
High
|
96
|
Oliver Sacks
|
37,395
|
1,206
|
B
|
Low
|
97
|
Neuron
|
37,345
|
1,204
|
B
|
Top
|
98
|
Ataxia
|
37,233
|
1,201
|
C
|
Mid
|
99
|
Sleep
|
36,672
|
1,182
|
B
|
Top
|
100
|
Adenosine triphosphate
|
36,271
|
1,170
|
C
|
Mid
|
101
|
Softmax function
|
36,256
|
1,169
|
C
|
Low
|
102
|
Stuttering
|
35,843
|
1,156
|
B
|
Mid
|
103
|
Electroencephalography
|
35,765
|
1,153
|
B
|
Top
|
104
|
Addiction
|
35,754
|
1,153
|
B
|
Mid
|
105
|
Autonomic nervous system
|
35,689
|
1,151
|
C
|
High
|
106
|
Aphantasia
|
35,618
|
1,148
|
Start
|
Low
|
107
|
Human brain
|
35,544
|
1,146
|
GA
|
Top
|
108
|
Robotics
|
34,863
|
1,124
|
B
|
Mid
|
109
|
Central nervous system
|
34,732
|
1,120
|
C
|
Top
|
110
|
Psychoactive drug
|
34,383
|
1,109
|
B
|
High
|
111
|
Cryonics
|
33,685
|
1,086
|
B
|
Mid
|
112
|
Nootropic
|
33,255
|
1,072
|
B
|
Mid
|
113
|
Mental state
|
32,699
|
1,054
|
B
|
Low
|
114
|
Information theory
|
32,528
|
1,049
|
B
|
Mid
|
115
|
Cerebrospinal fluid
|
32,191
|
1,038
|
GA
|
High
|
116
|
Taste
|
32,187
|
1,038
|
B
|
High
|
117
|
Hypothalamus
|
31,800
|
1,025
|
B
|
Top
|
118
|
Hippocampus
|
31,666
|
1,021
|
FA
|
Top
|
119
|
Recreational drug use
|
31,415
|
1,013
|
B
|
Mid
|
120
|
Acetylcholine
|
30,930
|
997
|
B
|
Mid
|
121
|
Antidepressant
|
30,888
|
996
|
B
|
Mid
|
122
|
Cognition
|
30,341
|
978
|
C
|
Top
|
123
|
Generalized anxiety disorder
|
29,999
|
967
|
C
|
Low
|
124
|
Perception
|
29,766
|
960
|
C
|
Mid
|
125
|
Neuroscience
|
29,755
|
959
|
B
|
Top
|
126
|
Atomoxetine
|
29,641
|
956
|
B
|
Mid
|
127
|
Limbic system
|
29,636
|
956
|
C
|
High
|
128
|
Proprioception
|
29,628
|
955
|
B
|
Mid
|
129
|
Sympathetic nervous system
|
29,552
|
953
|
C
|
High
|
130
|
Mental health
|
29,394
|
948
|
C
|
High
|
131
|
Positron emission tomography
|
29,360
|
947
|
B
|
Mid
|
132
|
Human eye
|
29,267
|
944
|
C
|
Mid
|
133
|
King's College London
|
29,241
|
943
|
GA
|
Low
|
134
|
Linguistic relativity
|
28,980
|
934
|
C
|
Mid
|
135
|
Basal ganglia
|
28,937
|
933
|
B
|
High
|
136
|
Nystagmus
|
28,763
|
927
|
Start
|
High
|
137
|
Γ-Aminobutyric acid
|
28,467
|
918
|
C
|
High
|
138
|
Fight-or-flight response
|
28,132
|
907
|
C
|
Mid
|
139
|
Acetylcysteine
|
27,978
|
902
|
B
|
Mid
|
140
|
Neurology
|
27,913
|
900
|
C
|
Top
|
141
|
Action potential
|
27,803
|
896
|
B
|
Top
|
142
|
Neurotransmitter
|
27,267
|
879
|
C
|
Top
|
143
|
Parasympathetic nervous system
|
27,034
|
872
|
C
|
High
|
144
|
Sense
|
26,037
|
839
|
B
|
High
|
145
|
Cyborg
|
25,791
|
831
|
C
|
Low
|
146
|
DNA sequencing
|
25,746
|
830
|
Unknown
|
Unknown
|
147
|
Coma
|
25,593
|
825
|
B
|
Mid
|
148
|
Vortioxetine
|
25,577
|
825
|
Start
|
Mid
|
149
|
Prefrontal cortex
|
25,405
|
819
|
C
|
High
|
150
|
Histamine
|
25,398
|
819
|
C
|
Mid
|
151
|
Neuroplasticity
|
25,303
|
816
|
B
|
Top
|
152
|
Hormone
|
25,225
|
813
|
C
|
High
|
153
|
Cerebellum
|
25,120
|
810
|
FA
|
Top
|
154
|
Free will
|
24,981
|
805
|
B
|
Mid
|
155
|
Mind–body dualism
|
24,927
|
804
|
B
|
Mid
|
156
|
Neural network
|
24,860
|
801
|
C
|
Mid
|
157
|
Cerebral cortex
|
24,716
|
797
|
B
|
Top
|
158
|
Psychiatry
|
24,441
|
788
|
B
|
Mid
|
159
|
Clozapine
|
24,199
|
780
|
B
|
Mid
|
160
|
Peripheral nervous system
|
24,100
|
777
|
C
|
Top
|
161
|
Medulla oblongata
|
24,100
|
777
|
C
|
Mid
|
162
|
Glutamic acid
|
24,081
|
776
|
C
|
Mid
|
163
|
Delta-8-Tetrahydrocannabinol
|
23,922
|
771
|
Start
|
Low
|
164
|
Personality
|
23,876
|
770
|
C
|
High
|
165
|
Operant conditioning
|
23,772
|
766
|
B
|
Mid
|
166
|
Brain–computer interface
|
23,486
|
757
|
B
|
Mid
|
167
|
Executive functions
|
23,112
|
745
|
B
|
High
|
168
|
Hans Asperger
|
22,922
|
739
|
C
|
Low
|
169
|
Hypnagogia
|
22,882
|
738
|
C
|
Mid
|
170
|
Trigeminal nerve
|
22,755
|
734
|
B
|
High
|
171
|
Terminal lucidity
|
22,620
|
729
|
Start
|
Low
|
172
|
G protein-coupled receptor
|
22,232
|
717
|
B
|
Mid
|
173
|
Rapid eye movement sleep
|
22,018
|
710
|
B
|
High
|
174
|
Pain
|
21,983
|
709
|
B
|
Top
|
175
|
Sleep deprivation
|
21,915
|
706
|
C
|
Mid
|
176
|
Hallucinogen persisting perception disorder
|
21,464
|
692
|
Start
|
Low
|
177
|
Brainstem
|
21,462
|
692
|
C
|
High
|
178
|
Phrenology
|
21,448
|
691
|
C
|
Low
|
179
|
Handedness
|
21,384
|
689
|
C
|
High
|
180
|
The Bell Curve
|
20,982
|
676
|
C
|
Mid
|
181
|
Korsakoff syndrome
|
20,548
|
662
|
C
|
Mid
|
182
|
NMDA receptor
|
20,514
|
661
|
C
|
High
|
183
|
Fear
|
20,474
|
660
|
B
|
Low
|
184
|
Adenosine
|
20,129
|
649
|
C
|
Mid
|
185
|
Frontotemporal dementia
|
19,739
|
636
|
C
|
Mid
|
186
|
Suicide legislation
|
19,461
|
627
|
C
|
Low
|
187
|
Philosophy of mind
|
19,414
|
626
|
B
|
Top
|
188
|
Albert Einstein's brain
|
19,352
|
624
|
B
|
Low
|
189
|
Neurosurgery
|
19,055
|
614
|
C
|
Mid
|
190
|
Cerebrum
|
18,739
|
604
|
C
|
Top
|
191
|
Wernicke–Korsakoff syndrome
|
18,713
|
603
|
C
|
Mid
|
192
|
University of Bristol
|
18,584
|
599
|
GA
|
Low
|
193
|
Frontal lobe
|
18,388
|
593
|
C
|
High
|
194
|
Cranial nerves
|
18,241
|
588
|
GA
|
Top
|
195
|
Bicameral mentality
|
18,025
|
581
|
Start
|
Low
|
196
|
Thalamus
|
18,017
|
581
|
C
|
High
|
197
|
Synapse
|
17,898
|
577
|
C
|
Top
|
198
|
Cognitive science
|
17,804
|
574
|
C
|
High
|
199
|
Self
|
17,696
|
570
|
C
|
High
|
200
|
Reinforcement
|
17,427
|
562
|
C
|
Mid
|
201
|
Frisson
|
17,425
|
562
|
Start
|
Low
|
202
|
Brachial plexus
|
17,412
|
561
|
C
|
Mid
|
203
|
Striatum
|
17,384
|
560
|
B
|
Mid
|
204
|
Motor neuron disease
|
16,903
|
545
|
C
|
High
|
205
|
Optical illusion
|
16,864
|
544
|
C
|
High
|
206
|
Intuition
|
16,823
|
542
|
C
|
High
|
207
|
Concussion
|
16,821
|
542
|
GA
|
High
|
208
|
Corpus callosum
|
16,658
|
537
|
C
|
High
|
209
|
Nightmare
|
16,266
|
524
|
C
|
Mid
|
210
|
Radiology
|
16,192
|
522
|
B
|
High
|
211
|
Polyvagal theory
|
15,964
|
514
|
Start
|
Low
|
212
|
Temporal lobe
|
15,789
|
509
|
Start
|
High
|
213
|
Theobromine
|
15,704
|
506
|
B
|
Mid
|
214
|
Vestibular system
|
15,652
|
504
|
C
|
Mid
|
215
|
Axon
|
15,631
|
504
|
B
|
Top
|
216
|
Neurodegenerative disease
|
15,472
|
499
|
C
|
High
|
217
|
Out-of-body experience
|
15,070
|
486
|
B
|
Low
|
218
|
Active transport
|
15,070
|
486
|
B
|
High
|
219
|
Amantadine
|
15,045
|
485
|
C
|
High
|
220
|
MTOR
|
15,011
|
484
|
B
|
Mid
|
221
|
Meninges
|
14,878
|
479
|
C
|
Mid
|
222
|
Endocannabinoid system
|
14,855
|
479
|
C
|
Mid
|
223
|
Delayed sleep phase disorder
|
14,851
|
479
|
B
|
Mid
|
224
|
Attention
|
14,753
|
475
|
C
|
High
|
225
|
Hypothalamic–pituitary–adrenal axis
|
14,718
|
474
|
C
|
High
|
226
|
Default mode network
|
14,469
|
466
|
B
|
Mid
|
227
|
Sleepwalking
|
14,462
|
466
|
C
|
Low
|
228
|
Grey matter
|
14,413
|
464
|
C
|
High
|
229
|
Pons
|
14,376
|
463
|
C
|
High
|
230
|
Executive dysfunction
|
14,347
|
462
|
B
|
Mid
|
231
|
Functional magnetic resonance imaging
|
14,347
|
462
|
B
|
High
|
232
|
Evolutionary psychology
|
14,201
|
458
|
C
|
Mid
|
233
|
Transfer function
|
14,160
|
456
|
Start
|
Low
|
234
|
Cortical homunculus
|
14,064
|
453
|
Start
|
Unknown
|
235
|
Legality of euthanasia
|
14,064
|
453
|
C
|
Mid
|
236
|
Confocal microscopy
|
14,062
|
453
|
C
|
Mid
|
237
|
Visual perception
|
13,913
|
448
|
B
|
High
|
238
|
Stroop effect
|
13,821
|
445
|
B
|
Mid
|
239
|
Myelin
|
13,790
|
444
|
C
|
High
|
240
|
Mind–body problem
|
13,755
|
443
|
C
|
High
|
241
|
Educational psychology
|
13,621
|
439
|
B
|
Unknown
|
242
|
Sense of smell
|
13,538
|
436
|
C
|
High
|
243
|
Somatosensory system
|
13,475
|
434
|
C
|
Top
|
244
|
Substance dependence
|
13,455
|
434
|
C
|
Mid
|
245
|
Hanger reflex
|
13,395
|
432
|
Stub
|
Low
|
246
|
Reward system
|
13,207
|
426
|
C
|
High
|
247
|
Wnt signaling pathway
|
13,189
|
425
|
C
|
Mid
|
248
|
Neurological disorder
|
13,182
|
425
|
Start
|
Mid
|
249
|
Cauda equina syndrome
|
13,167
|
424
|
C
|
Low
|
250
|
Substantia nigra
|
13,152
|
424
|
B
|
Mid
|
251
|
Stress (biology)
|
13,110
|
422
|
C
|
High
|
252
|
Brain transplant
|
13,081
|
421
|
C
|
Low
|
253
|
Parietal lobe
|
13,019
|
419
|
C
|
High
|
254
|
City University of New York
|
13,014
|
419
|
Unknown
|
Unknown
|
255
|
Altered state of consciousness
|
12,990
|
419
|
C
|
Unknown
|
256
|
Biopsychosocial model
|
12,971
|
418
|
Start
|
Mid
|
257
|
Opioid epidemic in the United States
|
12,957
|
417
|
C
|
Mid
|
258
|
Opiate
|
12,939
|
417
|
Start
|
Mid
|
259
|
Animal suicide
|
12,923
|
416
|
C
|
Low
|
260
|
Visual system
|
12,842
|
414
|
B
|
High
|
261
|
Facial nerve
|
12,837
|
414
|
C
|
Mid
|
262
|
Reticular formation
|
12,750
|
411
|
B
|
High
|
263
|
History of lysergic acid diethylamide
|
12,679
|
409
|
B
|
Mid
|
264
|
Humanoid robot
|
12,624
|
407
|
C
|
Mid
|
265
|
Glucagon-like peptide-1
|
12,623
|
407
|
Start
|
Low
|
266
|
Pleasure
|
12,565
|
405
|
C
|
High
|
267
|
Opioid epidemic
|
12,412
|
400
|
C
|
High
|
268
|
Lewy body
|
12,296
|
396
|
Start
|
Mid
|
269
|
Piracetam
|
12,157
|
392
|
C
|
Mid
|
270
|
Visual cortex
|
12,107
|
390
|
C
|
Mid
|
271
|
Reflex
|
12,105
|
390
|
Start
|
Top
|
272
|
Moro reflex
|
11,917
|
384
|
C
|
Low
|
273
|
Paranoid schizophrenia
|
11,781
|
380
|
NA
|
NA
|
274
|
Midbrain
|
11,774
|
379
|
C
|
High
|
275
|
Taste bud
|
11,720
|
378
|
C
|
Mid
|
276
|
Sex differences in intelligence
|
11,621
|
374
|
B
|
Low
|
277
|
Bacopa monnieri
|
11,585
|
373
|
C
|
Low
|
278
|
Psilocin
|
11,502
|
371
|
C
|
Low
|
279
|
G factor (psychometrics)
|
11,492
|
370
|
C
|
Low
|
280
|
Ten percent of the brain myth
|
11,401
|
367
|
C
|
Mid
|
281
|
5-HT2A receptor
|
11,396
|
367
|
B
|
Mid
|
282
|
Head transplant
|
11,277
|
363
|
Start
|
Low
|
283
|
Ganglion
|
11,204
|
361
|
Stub
|
Mid
|
284
|
Membrane potential
|
11,158
|
359
|
C
|
High
|
285
|
Neuropsychology
|
11,098
|
358
|
C
|
Top
|
286
|
Neocortex
|
10,952
|
353
|
C
|
High
|
287
|
Allodynia
|
10,936
|
352
|
C
|
Unknown
|
288
|
Insular cortex
|
10,898
|
351
|
B
|
High
|
289
|
Wernicke's area
|
10,854
|
350
|
C
|
High
|
290
|
Enteric nervous system
|
10,844
|
349
|
Start
|
Mid
|
291
|
Imagination
|
10,785
|
347
|
Start
|
High
|
292
|
Nucleus accumbens
|
10,661
|
343
|
B
|
High
|
293
|
Photoreceptor cell
|
10,645
|
343
|
C
|
Mid
|
294
|
University of California, San Francisco
|
10,503
|
338
|
B
|
Low
|
295
|
Universal grammar
|
10,495
|
338
|
Start
|
Mid
|
296
|
Immunohistochemistry
|
10,482
|
338
|
Start
|
Low
|
297
|
Nerve
|
10,409
|
335
|
C
|
High
|
298
|
Sweetness
|
10,265
|
331
|
B
|
Mid
|
299
|
Somatic nervous system
|
10,252
|
330
|
Start
|
Low
|
300
|
National Institute of Mental Health and Neurosciences
|
10,248
|
330
|
C
|
High
|
301
|
RNA-Seq
|
10,243
|
330
|
B
|
Low
|
302
|
Occipital lobe
|
10,233
|
330
|
Start
|
High
|
303
|
5-HT receptor
|
10,225
|
329
|
Start
|
High
|
304
|
Nonbenzodiazepine
|
10,218
|
329
|
Start
|
Low
|
305
|
Locus coeruleus
|
10,208
|
329
|
C
|
Mid
|
306
|
Mirror neuron
|
10,198
|
328
|
C
|
High
|
307
|
John C. Lilly
|
10,175
|
328
|
Start
|
Low
|
308
|
Henry Molaison
|
10,104
|
325
|
C
|
Mid
|
309
|
Neuromorphic engineering
|
10,089
|
325
|
B
|
Low
|
310
|
Instinct
|
9,998
|
322
|
Start
|
Top
|
311
|
Split-brain
|
9,989
|
322
|
C
|
High
|
312
|
Astrocyte
|
9,916
|
319
|
B
|
High
|
313
|
Acamprosate
|
9,889
|
319
|
Start
|
Low
|
314
|
Color vision
|
9,858
|
318
|
C
|
High
|
315
|
GABAA receptor
|
9,847
|
317
|
Start
|
Mid
|
316
|
Transient global amnesia
|
9,735
|
314
|
C
|
Mid
|
317
|
Episodic memory
|
9,640
|
310
|
Start
|
High
|
318
|
Deep brain stimulation
|
9,636
|
310
|
C
|
Mid
|
319
|
Microwave auditory effect
|
9,606
|
309
|
Start
|
Unknown
|
320
|
Depolarization
|
9,551
|
308
|
Start
|
High
|
321
|
Respiratory center
|
9,537
|
307
|
C
|
Unknown
|
322
|
Time perception
|
9,531
|
307
|
B
|
Mid
|
323
|
Odor
|
9,513
|
306
|
C
|
Low
|
324
|
Diencephalon
|
9,413
|
303
|
Start
|
High
|
325
|
Spinothalamic tract
|
9,393
|
303
|
Start
|
Low
|
326
|
Psycholinguistics
|
9,383
|
302
|
C
|
Top
|
327
|
Phrenic nerve
|
9,199
|
296
|
C
|
Low
|
328
|
Rizatriptan
|
9,136
|
294
|
Start
|
Low
|
329
|
Anterior cingulate cortex
|
9,133
|
294
|
C
|
Mid
|
330
|
Body integrity dysphoria
|
9,036
|
291
|
Start
|
Low
|
331
|
Reflex arc
|
9,016
|
290
|
Start
|
Mid
|
332
|
Ventral tegmental area
|
9,011
|
290
|
C
|
Mid
|
333
|
Ideomotor phenomenon
|
8,937
|
288
|
C
|
Low
|
334
|
Neural oscillation
|
8,929
|
288
|
B
|
High
|
335
|
Anti-psychiatry
|
8,926
|
287
|
C
|
Low
|
336
|
Microtome
|
8,881
|
286
|
Unknown
|
Unknown
|
337
|
Long-term potentiation
|
8,839
|
285
|
GA
|
High
|
338
|
Armodafinil
|
8,826
|
284
|
C
|
Mid
|
339
|
Higher consciousness
|
8,824
|
284
|
Start
|
Mid
|
340
|
Futures studies
|
8,764
|
282
|
Unknown
|
Unknown
|
341
|
Sensory nervous system
|
8,705
|
280
|
C
|
High
|
342
|
Lissencephaly
|
8,703
|
280
|
Start
|
Mid
|
343
|
Ventricular system
|
8,692
|
280
|
B
|
High
|
344
|
Single-photon emission computed tomography
|
8,692
|
280
|
C
|
Mid
|
345
|
Saccade
|
8,680
|
280
|
C
|
High
|
346
|
Triune brain
|
8,664
|
279
|
Start
|
Mid
|
347
|
Dorsal column–medial lemniscus pathway
|
8,641
|
278
|
C
|
Low
|
348
|
Monoamine oxidase A
|
8,624
|
278
|
Start
|
Mid
|
349
|
Lateralization of brain function
|
8,593
|
277
|
C
|
High
|
350
|
Internal capsule
|
8,568
|
276
|
Start
|
Mid
|
351
|
Electrical conduction system of the heart
|
8,405
|
271
|
C
|
Low
|
352
|
White matter
|
8,402
|
271
|
C
|
High
|
353
|
Mental image
|
8,367
|
269
|
Start
|
Unknown
|
354
|
Weber–Fechner law
|
8,365
|
269
|
Start
|
Mid
|
355
|
Computational biology
|
8,348
|
269
|
C
|
Mid
|
356
|
Dendrite
|
8,302
|
267
|
C
|
Top
|
357
|
Cushing reflex
|
8,267
|
266
|
C
|
Low
|
358
|
Human intelligence
|
8,198
|
264
|
C
|
High
|
359
|
Gate control theory
|
8,182
|
263
|
C
|
Low
|
360
|
Repressed memory
|
8,174
|
263
|
C
|
Mid
|
361
|
Nervous tissue
|
8,156
|
263
|
C
|
High
|
362
|
Vomeronasal organ
|
8,143
|
262
|
C
|
Mid
|
363
|
Consciousness after death
|
8,139
|
262
|
Start
|
Mid
|
364
|
Altered level of consciousness
|
8,109
|
261
|
C
|
Mid
|
365
|
Pungency
|
8,100
|
261
|
C
|
Mid
|
366
|
Second messenger system
|
8,100
|
261
|
Start
|
Mid
|
367
|
Referred pain
|
8,080
|
260
|
B
|
High
|
368
|
Mesolimbic pathway
|
8,011
|
258
|
C
|
Mid
|
369
|
Neurotypical
|
8,010
|
258
|
Start
|
Mid
|
370
|
Hebbian theory
|
7,935
|
255
|
Start
|
Top
|
371
|
Neurofeedback
|
7,911
|
255
|
Start
|
Mid
|
372
|
Neuromuscular-blocking drug
|
7,886
|
254
|
C
|
Mid
|
373
|
Tickling
|
7,878
|
254
|
Start
|
Low
|
374
|
GABA receptor
|
7,867
|
253
|
Start
|
High
|
375
|
Neuroscientist
|
7,857
|
253
|
C
|
High
|
376
|
List of gravity hills
|
7,842
|
252
|
List
|
Mid
|
377
|
Hearing
|
7,822
|
252
|
Start
|
High
|
378
|
Anosognosia
|
7,787
|
251
|
C
|
Mid
|
379
|
Neuralgia
|
7,782
|
251
|
C
|
Mid
|
380
|
Monoamine oxidase
|
7,765
|
250
|
Start
|
High
|
381
|
Adult attention deficit hyperactivity disorder
|
7,733
|
249
|
B
|
Low
|
382
|
5-HT1A receptor
|
7,714
|
248
|
Start
|
Mid
|
383
|
List of animals by number of neurons
|
7,699
|
248
|
List
|
Low
|
384
|
Mathematical and theoretical biology
|
7,696
|
248
|
Unknown
|
Unknown
|
385
|
Monoamine neurotransmitter
|
7,671
|
247
|
C
|
High
|
386
|
Torpor
|
7,657
|
247
|
C
|
Low
|
387
|
Hemispatial neglect
|
7,617
|
245
|
C
|
High
|
388
|
Brooklyn College
|
7,606
|
245
|
Start
|
Low
|
389
|
Music therapy
|
7,584
|
244
|
B
|
Low
|
390
|
Human sex pheromones
|
7,578
|
244
|
Start
|
Low
|
391
|
Hyperintensity
|
7,528
|
242
|
Start
|
Mid
|
392
|
Alex (parrot)
|
7,490
|
241
|
C
|
Mid
|
393
|
Cognitive skill
|
7,476
|
241
|
Start
|
Unknown
|
394
|
Orbitofrontal cortex
|
7,445
|
240
|
B
|
Mid
|
395
|
Optic nerve
|
7,437
|
239
|
C
|
Mid
|
396
|
Glutamate (neurotransmitter)
|
7,299
|
235
|
Start
|
High
|
397
|
Lesch–Nyhan syndrome
|
7,257
|
234
|
B
|
Low
|
398
|
Neural circuit
|
7,243
|
233
|
C
|
High
|
399
|
Santiago Ramón y Cajal
|
7,203
|
232
|
C
|
High
|
400
|
Μ-opioid receptor
|
7,152
|
230
|
C
|
Mid
|
401
|
Dopaminergic pathways
|
7,143
|
230
|
C
|
Mid
|
402
|
Sensory neuron
|
7,143
|
230
|
C
|
High
|
403
|
Diffusion MRI
|
7,137
|
230
|
C
|
Mid
|
404
|
Orexin
|
7,137
|
230
|
C
|
High
|
405
|
Neurobiological effects of physical exercise
|
7,087
|
228
|
B
|
Mid
|
406
|
Brodmann area
|
7,083
|
228
|
Start
|
Top
|
407
|
Computational neuroscience
|
7,083
|
228
|
B
|
Top
|
408
|
Cerebral hemisphere
|
7,054
|
227
|
C
|
High
|
409
|
Dopamine receptor
|
7,005
|
225
|
B
|
High
|
410
|
Chronic pain
|
6,995
|
225
|
C
|
High
|
411
|
Brain size
|
6,991
|
225
|
Start
|
Unknown
|
412
|
Theta wave
|
6,932
|
223
|
C
|
High
|
413
|
Electrophysiology
|
6,915
|
223
|
C
|
High
|
414
|
Creativity and mental health
|
6,910
|
222
|
Start
|
Mid
|
415
|
Klüver–Bucy syndrome
|
6,903
|
222
|
Start
|
Low
|
416
|
Drug class
|
6,880
|
221
|
C
|
High
|
417
|
Olfactory system
|
6,879
|
221
|
C
|
Mid
|
418
|
Unconsciousness
|
6,866
|
221
|
Start
|
Mid
|
419
|
Gliosis
|
6,845
|
220
|
C
|
Low
|
420
|
Major depressive episode
|
6,790
|
219
|
C
|
Mid
|
421
|
Sodium channel
|
6,789
|
219
|
B
|
Mid
|
422
|
Lateral geniculate nucleus
|
6,788
|
218
|
C
|
High
|
423
|
Optogenetics
|
6,752
|
217
|
C
|
High
|
424
|
Amusia
|
6,741
|
217
|
B
|
Mid
|
425
|
Artificial consciousness
|
6,726
|
216
|
C
|
Unknown
|
426
|
Vascular endothelial growth factor
|
6,713
|
216
|
C
|
Low
|
427
|
Dorsolateral prefrontal cortex
|
6,678
|
215
|
C
|
Mid
|
428
|
Slow-wave sleep
|
6,661
|
214
|
C
|
Mid
|
429
|
List of psychoactive drugs used by militaries
|
6,630
|
213
|
List
|
Low
|
430
|
Motor neuron
|
6,619
|
213
|
C
|
Mid
|
431
|
Ion channel
|
6,615
|
213
|
B
|
Top
|
432
|
Oculomotor nerve
|
6,614
|
213
|
C
|
Mid
|
433
|
Acedia
|
6,606
|
213
|
Start
|
Low
|
434
|
Semicircular canals
|
6,586
|
212
|
C
|
Mid
|
435
|
Behavioural genetics
|
6,519
|
210
|
GA
|
Mid
|
436
|
Accessory nerve
|
6,502
|
209
|
GA
|
Mid
|
437
|
Glossopharyngeal nerve
|
6,476
|
208
|
C
|
High
|
438
|
Matthew Walker (scientist)
|
6,473
|
208
|
C
|
High
|
439
|
Hodgkin–Huxley model
|
6,424
|
207
|
B
|
High
|
440
|
Ligand-gated ion channel
|
6,397
|
206
|
C
|
High
|
441
|
In silico
|
6,382
|
205
|
C
|
Mid
|
442
|
Cingulate cortex
|
6,380
|
205
|
C
|
High
|
443
|
Hilary Putnam
|
6,364
|
205
|
FA
|
Low
|
444
|
Cognitive neuroscience
|
6,354
|
204
|
Unknown
|
Unknown
|
445
|
Eliminative materialism
|
6,321
|
203
|
GA
|
Mid
|
446
|
Brain-to-body mass ratio
|
6,293
|
203
|
Start
|
Mid
|
447
|
Primitive reflexes
|
6,257
|
201
|
Start
|
Top
|
448
|
AMPA receptor
|
6,213
|
200
|
C
|
High
|
449
|
Central nervous system disease
|
6,204
|
200
|
Start
|
High
|
450
|
Opioid receptor
|
6,201
|
200
|
Start
|
High
|
451
|
Chemical synapse
|
6,197
|
199
|
B
|
Top
|
452
|
History of opium in China
|
6,197
|
199
|
C
|
Low
|
453
|
Encephalization quotient
|
6,150
|
198
|
Start
|
Low
|
454
|
Refractory period (physiology)
|
6,096
|
196
|
C
|
Low
|
455
|
Psychonautics
|
6,095
|
196
|
C
|
Low
|
456
|
Neuroimaging
|
6,074
|
195
|
B
|
Top
|
457
|
Caudate nucleus
|
6,055
|
195
|
C
|
Mid
|
458
|
Gut–brain axis
|
5,948
|
191
|
B
|
Low
|
459
|
Pyramidal tracts
|
5,941
|
191
|
B
|
Mid
|
460
|
Cetacean intelligence
|
5,908
|
190
|
C
|
Mid
|
461
|
Sleep cycle
|
5,869
|
189
|
C
|
High
|
462
|
Cerebrospinal fluid leak
|
5,865
|
189
|
C
|
Unknown
|
463
|
Fei-Fei Li
|
5,837
|
188
|
C
|
Low
|
464
|
Debra Soh
|
5,812
|
187
|
C
|
Low
|
465
|
Hunger (physiology)
|
5,809
|
187
|
Start
|
Mid
|
466
|
Motor cortex
|
5,801
|
187
|
C
|
High
|
467
|
Blindsight
|
5,797
|
187
|
Start
|
Mid
|
468
|
Military robot
|
5,769
|
186
|
Unknown
|
Unknown
|
469
|
Mandibular nerve
|
5,761
|
185
|
Start
|
Low
|
470
|
Recall (memory)
|
5,747
|
185
|
B
|
High
|
471
|
Trochlear nerve
|
5,670
|
182
|
C
|
Mid
|
472
|
Auditory cortex
|
5,661
|
182
|
C
|
High
|
473
|
Dorsal root ganglion
|
5,660
|
182
|
C
|
Mid
|
474
|
Corona radiata
|
5,659
|
182
|
Start
|
High
|
475
|
Sex differences in psychology
|
5,632
|
181
|
C
|
High
|
476
|
Vestibulocochlear nerve
|
5,619
|
181
|
Start
|
High
|
477
|
Hypoglossal nerve
|
5,605
|
180
|
GA
|
High
|
478
|
Organ of Corti
|
5,596
|
180
|
C
|
Mid
|
479
|
Ventromedial prefrontal cortex
|
5,594
|
180
|
Start
|
Mid
|
480
|
Polysomnography
|
5,589
|
180
|
C
|
Mid
|
481
|
CIFAR-10
|
5,586
|
180
|
Start
|
Low
|
482
|
List of regions in the human brain
|
5,572
|
179
|
List
|
Top
|
483
|
Suprachiasmatic nucleus
|
5,570
|
179
|
C
|
High
|
484
|
Solitary nucleus
|
5,570
|
179
|
Start
|
Mid
|
485
|
Gamma wave
|
5,563
|
179
|
Start
|
Mid
|
486
|
Schwann cell
|
5,554
|
179
|
C
|
Mid
|
487
|
Artificial neuron
|
5,549
|
179
|
Start
|
Mid
|
488
|
Phantom limb
|
5,512
|
177
|
C
|
Mid
|
489
|
Salience (neuroscience)
|
5,461
|
176
|
Start
|
High
|
490
|
Tibial nerve
|
5,443
|
175
|
Start
|
Low
|
491
|
V. S. Ramachandran
|
5,436
|
175
|
C
|
Low
|
492
|
Amygdala hijack
|
5,427
|
175
|
Start
|
Mid
|
493
|
Putamen
|
5,394
|
174
|
Start
|
Mid
|
494
|
Behavioral neuroscience
|
5,391
|
173
|
C
|
Mid
|
495
|
Pain in crustaceans
|
5,376
|
173
|
B
|
Mid
|
496
|
Primary motor cortex
|
5,335
|
172
|
C
|
High
|
497
|
Psychedelic therapy
|
5,327
|
171
|
B
|
Mid
|
498
|
Melanocyte-stimulating hormone
|
5,299
|
170
|
Start
|
Mid
|
499
|
Superior colliculus
|
5,258
|
169
|
C
|
Mid
|
500
|
Κ-opioid receptor
|
5,239
|
169
|
C
|
Mid
|